BlackRock Fund Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$9K	Hold	632	–	–	﹤0.01%	3979
2016 Q3	$8K	Buy	632 +27	+4%	+$262	﹤0.01%	3997
2016 Q2	$6K	Sell	605 -67,014	-99%	-$804K	﹤0.01%	4064
2016 Q1	$568K	Sell	67,619 -2,265	-3%	-$18.9K	﹤0.01%	3225
2015 Q4	$861K	Sell	69,884 -53,293	-43%	-$1.46M	﹤0.01%	3245
2015 Q3	$7.5M	Buy	123,177 +5,472	+5%	+$395K	﹤0.01%	2554
2015 Q2	$9.19M	Buy	117,705 +24,492	+26%	+$2.06M	﹤0.01%	2558
2015 Q1	$6.33M	Buy	93,213 +4,381	+5%	+$376K	﹤0.01%	2708
2014 Q4	$8.24M	Buy	88,832 +8,299	+10%	+$858K	﹤0.01%	2575
2014 Q3	$8.48M	Buy	80,533 +8,336	+12%	+$1.16M	﹤0.01%	2451
2014 Q2	$10.3M	Buy	72,197 +2,170	+3%	+$317K	﹤0.01%	2393
2014 Q1	$10.6M	Buy	70,027 +4,509	+7%	+$888K	﹤0.01%	2373
2013 Q4	$12M	Buy	65,518 +11,064	+20%	+$2.03M	﹤0.01%	2278
2013 Q3	$12M	Buy	54,454 +6,750	+14%	+$1.44M	﹤0.01%	2244
2013 Q2	$8.33M	Buy	+47,704	New	+$12.4M	﹤0.01%	2367